If you need more lookups,
subscriptions start at $34 USD/month.
Stephen Mitchener Location
Cambridge, MA, US
Stephen Mitchener Work
2023 -now Chief Business Officer @
2020 -2023 SVP, Chief Business Officer @
2019 -2020 Sr. VP, Chief Business Officer and Head Strategic Finance @
2018 -2020 Sr. Vice President and Chief Business Officer @
2017 -2018 Board Observer @
2016 -2018 Head US Oncology Strategy, Partnering and Operations @
2016 -2017 VP and Head of Strategic Data, Ad Interim @
2013 -2016 Oncology Business Franchise Head- Australia and New Zealand @
2011 -2013 Director, Global Pharma Strategy @
2009 -2011 Director, Global Strategic Marketing and New Products, Integrated Hospital Care Franchise @
2006 -2008 Senior Brand Manager, Tasigna Us Brand Team @
2005 -2006 Specialist, Novartis Oncology Sales @
2003 -2005 Novartis Oncology Marketing Fellow @ Ernest Mario School of Pharmacy Rutgers Post-Doctoral Pharmaceutical Industry Fe
2003 -2005 Gleevec Us Marketing @
Stephen Mitchener Education
RU 2003-2005
University of North Carolina at Chapel Hill
Doctor of Pharmacy (Pharmacy)
1997-2003
Stephen Mitchener Skills
Pharmaceutical Industry
Oncology
Strategy
Clinical Trials
Integrated Marketing
Market Access
Urology
Pharmaceutical Sales
Global Marketing
Sales
Marketing
Biotechnology
Cross-functional Team Leadership
Strategic Planning
Marketing Management
Product Launch
Medical Affairs
Clinical Development
Market Analysis
Cross Functional Team Leadership
Cross Functional Team
Stephen Mitchener Summary
Stephen Mitchener, based in Cambridge, MA, US, is currently a Chief Business Officer at Alpha-9 Oncology. Stephen Mitchener brings experience from previous roles at Karyopharm Therapeutics Inc., Axcella and Cota Healthcare. Stephen Mitchener holds a 2003 - 2005 RU. With a robust skill set that includes Pharmaceutical Industry, Oncology, Strategy, Clinical Trials, Integrated Marketing and more. Stephen Mitchener has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Stephen Mitchener?
Find contact details for 700 million professionals.